Practical management of C1 inhibitor deficiency;Manejo práctico del déficit de C1 inhibidor

Actas Dermo-Sifiliograficas

Volumn 98, Issue 4, 2007, Pages 240-249

  Pedraz Muñoz, Javier ^a   Dauden E ^a   Garcia Diez A ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Androgens; Angioedema; Antifibrinolytics; C1 inhibitor deficiency

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; AMINOCAPROIC ACID; ANABOLIC AGENT; ANDROGEN; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN III; BERINERT; BETA 2 MICROGLOBULIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12A; CAPROAMIN FIDES; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; DX 88; FRESH FROZEN PLASMA; ICATIBANT; KALLIKREIN INHIBITOR; LONGIVOL; METHYLTESTOSTERONE; OXANDROLONE; STANOZOLOL; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ACNE; ALOPECIA; ANGIONEUROTIC EDEMA; ARTICLE; ATHEROGENESIS; CHEMOPROPHYLAXIS; CHOLESTASIS; CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; COMPLEMENT COMPONENT C1S INHIBITOR DEFICIENCY; COMPLEMENT DEFICIENCY; CREATINE KINASE BLOOD LEVEL; DENTAL SURGERY; DEPRESSION; DIARRHEA; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FATIGUE; GASTROINTESTINAL OBSTRUCTION; HEADACHE; HIRSUTISM; HUMAN; HYPERTENSION; LARYNX STENOSIS; LIBIDO DISORDER; LIVER ADENOMA; LIVER DYSFUNCTION; LIVER NECROSIS; MENSTRUATION DISORDER; MYALGIA; NAUSEA; ORAL SURGERY; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PELIOSIS HEPATIS; PRACTICE GUIDELINE; PRECOCIOUS PUBERTY; PROSTATE ADENOCARCINOMA; RHABDOMYOLYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOSIS; VERTIGO; VIRILIZATION;

EID: 34347363110     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70057-1     Document Type: Article

References (31)

1. Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L, et al. Canadian 2003 International Consensus Algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol. 2004;114:629-37.
2. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139:379-94.
3. Fabiana JE, Avigliano A, Dupont JC. Hereditary angioedema. Long-term follow-up of 88 patients. Experience of the Argentine Allergy and Immunology Institute. Allergol Immunopathol. 2000; 28:267-71.
4. Bork K, Barnstedt S, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356:213-7.
5. Starr JC, Brasher GW. Erythema marginatum preceding hereditary angioedema. J Allergy Clin Immunol. 1974;53:352-5.
6. Williamson DM. Reticulate erythema - a prodrome in hereditary angio-oedema. Br J Dermatol. 1979;101:549-52.
7. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976;84:580-93.
8. Karlis V, Glickman RS, Stern R, Kinney L. Hereditary angio-edema: case report and review of management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:462-4.
9. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med. 2003;114:294-8.
10. Chappatte O, De Swiet M. Hereditary angioneurotic oedema and pregnancy. Case reports and review of the literature. Br J Obstet Gynaecol. 1988;95:938-42.
11. Rais M, Unzeiting J, Grant JA. Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection. J Allergy Clin Immunol. 1999;103:713-4.
12. Farkas H, Gyeney L, Majthenyi P, Fust G, Varga L. Angio-edema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol. 1999;37:513-8.
13. Longan RA, Greaves MW. Hereditary angio-oedema: treatment with C1 esterase inhibitor concentrate. J R Soc Med. 1984;77:1046-8.
14. Gompels MM, Lock RJ, Morgan JE, Osborne J, Brown A, Virgo PF. A multi-centre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol. 2002;55:145-7.
15. Compels MM, Lock RJ. C1 inhibitor deficiency: diagnosis. Clin Exp Dermatol. 2005;30:460-2.
16. Nielsen EW, Johansen HT, Holt J, Mollnes TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res. 1994;35:184-7.
17. Weiler CR, Van Dellen RG. Genetic test indications and interpretations in patiens with hereditary angioedema. Mayo Clin Proc. 2006;81:958-72.
18. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med. 1976;295:1444-8.
19. Agostini A, Cicardi M, Martignoni GC, Bergamaschini L, Marasini B. Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. J Allergy Clin Immunol. 1980;65:75-9.
20. Sheffer AL, Fearson DT, Austen KF. Hereditary angioedema: a decade of management with stanozolol. J Allergy Clin Immunol. 1987;80:855-60.
21. Bork K, Pitton M, Harten P, Koch P. Hepatocelular adenomas in patients taking danazol for hereditary angio-edema. Lancet. 1999;353:1066-7.
22. Frank MM, Sergent JS, Kane MA, Alling DW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double blind study. N Engl J Med. 1972;286:808-12.
23. Bork K, Barnstedt S. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001;161:714-8.
24. Naish P, Barratt J. Hereditary angioedema. Lancet. 1979;i:611.
25. Bork K, Siedlecki K, Bosch S, Schopf R, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angio-edema. Mayo Clin Proc. 2000;75:349-54.
26. Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostini A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencias. Medicine (Baltimore). 2003;82:274-81.
27. Herrmann G, Schneider L, Krieg T, Hunzelmann N, Scharffetter-Kochanek K. Efficacy of danazol treatment in a patient with the new variant of hereditary angio-edema (HAE III). Br J Dermatol. 2004;150:155-77.
28. Frank MM. Urticaria and angioedema. En: Goldman L, Bennett JC, editors. Cecil Textbook of Medicine. 21st ed. Philadelphia: WB Saunders; 2000. p. 1440-5.
29. Laurent J, Guinnepain MT. Angioedema associated with C1 inhibitor deficiency. Clin Rev Allergy Immunol. 1999;17:513-23.
30. Bas M, Bier H, Greve J, Kojda G, Hoffmann TK. Novel pharmacotherapy of acute hereditary angioedema with dradykinin B2-receptor antagonist icatibant. Allergy. 2006;61:1490-2.
31. Van Doom MB, Burggraaf J, Van Dam T, Eerenberg A, Levi M, Hack CE, et al. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angio-edema. J Allergy Clin Immunol. 2005;116:876-83.